Rhabdomyosarcoma of the uterus in an adult patient with osteopetrosis: a case report.
Rhabdomyosarcoma
Sarcoma
Uterus
Journal
Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382
Informations de publication
Date de publication:
28 Nov 2021
28 Nov 2021
Historique:
received:
14
04
2021
accepted:
28
10
2021
entrez:
28
11
2021
pubmed:
29
11
2021
medline:
1
12
2021
Statut:
epublish
Résumé
Uterine sarcoma accounts for 3-7% of uterine malignant neoplasms. It is more aggressive than epithelial neoplasms, and patients have a poor prognosis. Rhabdomyosarcoma is classified as a heterologous uterine sarcoma. It is the most common soft tissue malignancy in children while rare in adults. In young patients, the majority of genital tract rhabdomyosarcomas occur in vagina; however, the most common site of gynecologic rhabdomyosarcoma is cervix followed by uterine corpus, in adults. Uterine corpus rhabdomyosarcoma is rare in adults. Diagnosis of pure rhabdomyosarcoma in uterus involves widespread and perfect sampling as well as precise histopathological evaluation to uncover any epithelial component. Here we report a case of pure rhabdomyosarcoma of uterine corpus in a 60-year-old Iranian postmenopausal female who had osteopetrosis, presenting with 8-month heavy vaginal bleeding and a protruding cervical mass. She is alive on 18-month follow-up after treatment. Rhabdomyosarcoma of uterine corpus is rare in adults. Diagnosis of pure rhabdomyosarcoma in uterus involves widespread and perfect sampling as well as precise histopathological evaluation to uncover any epithelial component. Treatment options in adult gynecological rhabdomyosarcoma are based on studies in younger patients, and more studies may help us choose the best approach for improving outcome.
Sections du résumé
BACKGROUND
BACKGROUND
Uterine sarcoma accounts for 3-7% of uterine malignant neoplasms. It is more aggressive than epithelial neoplasms, and patients have a poor prognosis. Rhabdomyosarcoma is classified as a heterologous uterine sarcoma. It is the most common soft tissue malignancy in children while rare in adults. In young patients, the majority of genital tract rhabdomyosarcomas occur in vagina; however, the most common site of gynecologic rhabdomyosarcoma is cervix followed by uterine corpus, in adults. Uterine corpus rhabdomyosarcoma is rare in adults. Diagnosis of pure rhabdomyosarcoma in uterus involves widespread and perfect sampling as well as precise histopathological evaluation to uncover any epithelial component.
CASE PRESENTATION
METHODS
Here we report a case of pure rhabdomyosarcoma of uterine corpus in a 60-year-old Iranian postmenopausal female who had osteopetrosis, presenting with 8-month heavy vaginal bleeding and a protruding cervical mass. She is alive on 18-month follow-up after treatment.
CONCLUSIONS
CONCLUSIONS
Rhabdomyosarcoma of uterine corpus is rare in adults. Diagnosis of pure rhabdomyosarcoma in uterus involves widespread and perfect sampling as well as precise histopathological evaluation to uncover any epithelial component. Treatment options in adult gynecological rhabdomyosarcoma are based on studies in younger patients, and more studies may help us choose the best approach for improving outcome.
Identifiants
pubmed: 34838127
doi: 10.1186/s13256-021-03172-y
pii: 10.1186/s13256-021-03172-y
pmc: PMC8627611
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
570Informations de copyright
© 2021. The Author(s).
Références
Cancer. 1995 Jan 1;75(1 Suppl):395-405
pubmed: 8001010
J Urol. 1992 Dec;148(6):1761-8
pubmed: 1433603
Sarcoma. 2001;5(1):9-15
pubmed: 18521303
Int J Gynecol Pathol. 2010 Mar;29(2):122-34
pubmed: 20173498
J Clin Oncol. 2010 May 1;28(13):2151-8
pubmed: 20351326
Am J Surg Pathol. 2007 Mar;31(3):382-9
pubmed: 17325479
Med Oncol. 2019 May 18;36(7):59
pubmed: 31104202
Int J Gynecol Cancer. 2020 Jan;30(1):21-28
pubmed: 31780571
Cancer. 2003 Aug 1;98(3):571-80
pubmed: 12879475
Arch Gynecol Obstet. 2018 Mar;297(3):559-572
pubmed: 29159540
Surg Pathol Clin. 2019 Jun;12(2):363-396
pubmed: 31097109
Am J Clin Pathol. 1978 Aug;70(2):217-23
pubmed: 696680
Oncol Res Treat. 2018;41(11):674
pubmed: 30326471
Gynecol Oncol. 1999 Dec;75(3):509-13
pubmed: 10600318
Histopathology. 2020 Jan;76(1):151-156
pubmed: 31846528
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:51-58
pubmed: 30306577
Hum Pathol. 2018 Apr;74:122-128
pubmed: 29320751